tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market
Advertisement

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
10,459 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 3.33, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 67.49, while Crispr Therapeutics AG’s (CRSP) share price is $68.43, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 62.16, while Crispr Therapeutics AG’s (CRSP) share price is $68.43, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Oct 18, 2025, 08:37 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
66.76
68.28
70.05
71.57
73.34
74.86
76.63
Fibonacci
68.28
69.54
70.31
71.57
72.83
73.60
74.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Oct 18, 2025, 08:37 AM
Period
Simple
Exponential
MA5
70.20Sell
70.18Sell
MA10
71.12Sell
69.89Sell
MA20
67.35Buy
67.49Buy
MA50
60.23Buy
62.16Buy
MA100
55.31Buy
56.87Buy
MA200
47.73Buy
51.05Buy
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 69.89, while Crispr Therapeutics AG’s (CRSP) share price is $68.43, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 56.87, while Crispr Therapeutics AG’s (CRSP) share price is $68.43, making it a Buy.
Crispr Therapeutics AG’s (CRSP) stock price is $68.43 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 60.23, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $68.43 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 55.31, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $68.43 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 47.73, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Oct 18, 2025, 08:37 AM
Name
Value
Implied Action
RSI (14)
54.06
Neutral
STOCH (9,6)
37.11
Neutral
STOCHRSI (14)
53.99
Neutral
MACD (12,26)
3.33
Buy
ADX (14)
31.37
Neutral
Williams %R
-59.40
Buy
CCI (14)
28.71
Neutral
ATR (14)
4.40
-
Ultimate Oscillator
47.47
Neutral
ROC
10.96
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 54.06, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 31.37, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 28.71, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 10.96, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 54.06, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 3.33, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 70.20, which suggests CRSP is a Sell.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 67.35, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 60.23, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 47.73, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -59.40, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 28.71, which suggests CRSP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis